GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Gross Profit

Smith & Nephew (Smith & Nephew) Gross Profit

: $3,819 Mil (TTM As of Dec. 2023)
View and export this data going back to 1999. Start your Free Trial

Smith & Nephew's gross profit for the six months ended in Dec. 2023 was $1,921 Mil. Smith & Nephew's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $3,819 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Smith & Nephew's gross profit for the six months ended in Dec. 2023 was $1,921 Mil. Smith & Nephew's Revenue for the six months ended in Dec. 2023 was $2,815 Mil. Therefore, Smith & Nephew's Gross Margin % for the quarter that ended in Dec. 2023 was 68.24%.

Smith & Nephew had a gross margin of 68.24% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Smith & Nephew was 75.33%. The lowest was 68.82%. And the median was 73.15%.

Warning Sign:

Smith & Nephew PLC gross margin has been in long-term decline. The average rate of decline per year is -1.3%.


Smith & Nephew Gross Profit Historical Data

The historical data trend for Smith & Nephew's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,800.00 3,164.00 3,669.00 3,675.00 3,819.00

Smith & Nephew Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,876.00 1,827.00 1,848.00 1,898.00 1,921.00

Competitive Comparison

For the Medical Devices subindustry, Smith & Nephew's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew Gross Profit Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Gross Profit distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Gross Profit falls into.



Smith & Nephew Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Smith & Nephew's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=5549 - 1730
=3,819

Smith & Nephew's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=2815 - 894
=1,921

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $3,819 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Smith & Nephew's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=1,921 / 2815
=68.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Smith & Nephew  (NYSE:SNN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Smith & Nephew had a gross margin of 68.24% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Smith & Nephew Gross Profit Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Smith & Nephew (Smith & Nephew) Business Description

Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (Smith & Nephew) Headlines

From GuruFocus

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022

Smith+Nephew acquires novel cementless partial knee system

By PRNewswire PRNewswire 01-19-2022